Advanced stage melanoma management with cutting-edge diagnostic and therapeutic strategies.
Our Stage 4 melanoma protocol represents the forefront of advanced melanoma care, combining comprehensive PET-CT imaging with molecular diagnostics to guide treatment decisions in metastatic disease. This protocol integrates nuclear medicine techniques with immunotherapy and targeted therapy monitoring, providing real-time assessment of treatment response. The comprehensive approach includes detailed metastatic disease mapping, treatment response evaluation, and ongoing surveillance to optimize patient outcomes in advanced melanoma.
Patients with stage 4 melanoma, extensive metastatic disease, or those on immunotherapy/targeted therapy requiring detailed treatment response assessment.
Complete the form below to begin your treatment journey with our comprehensive cancer care protocol